4.8 Review

Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches

Journal

GASTROENTEROLOGY
Volume 139, Issue 5, Pages 1481-1496

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2010.09.004

Keywords

Primary Biliary Cirrhosis; Primary Sclerosing Cholangitis; Cholestasis; Ursodeoxycholic Acid

Funding

  1. Axcan Pharma
  2. Canadian Institutes for Health Research [MOP 74621]
  3. Canadian Primary Biliary Cirrhosis Society
  4. National Institutes of Health [DK39588]

Ask authors/readers for more resources

Cholestatic liver disorders are caused by genetic defects, mechanical aberrations, toxins, or dysregulations in the immune system that damage the bile ducts and cause accumulation of bile and liver tissue damage. They have common clinical manifestations and pathogenic features that include the responses of cholangiocytes and hepatocytes to injury. We review the features of bile acid transport, tissue repair and regulation, apoptosis, vascular supply, immune regulation, and cholangiocytes that are associated with cholestatic liver disorders. We now have a greater understanding of the physiology of cholangiocytes at the cellular and molecular levels, as well as genetic factors, repair pathways, and autoimmunity mechanisms involved in the pathogenesis of disease. These discoveries will hopefully lead to new therapeutic approaches for patients with cholestatic liver disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available